Qube Research & Technologies (QRT)
ALLO icon

Qube Research & Technologies (QRT)’s Allogene Therapeutics ALLO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.89M Buy
+1,178,377
New +$2.24M ﹤0.01% 2349
2024
Q1 		– Sell
-585,706
Closed -$1.88M – 4434
2023
Q4 		$1.88M Buy
+585,706
New +$1.66M ﹤0.01% 1562
2023
Q2 		– Sell
-135,244
Closed -$668K – 2359
2023
Q1 		$668K Sell
135,244
-51,833
-28% -$332K ﹤0.01% 1451
2022
Q4 		$1.18M Buy
187,077
+70,020
+60% +$648K 0.01% 1150
2022
Q3 		$1.26M Buy
+117,057
New +$1.59M 0.01% 1108

Other funds holding ALLO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pfizer
Pfizer New York $164M AUM 53.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALLO Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 1,178,377 shares worth $1.89M. The stake represents ﹤0.01% of the portfolio and ranks #2349 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ALLO as recently as Q4 2023.

Qube Research & Technologies (QRT) first reported a position in ALLO in Q3 2022 and has held it in 5 quarters since. 141 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.

  • Qube Research & Technologies (QRT) held 1,178,377 shares of Allogene Therapeutics worth $1.89M as of Q3 2026.
  • Allogene Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Allogene Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2349 holding.
  • Qube Research & Technologies (QRT) first reported a position in Allogene Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • 141 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.